• Corporate Events Alaska Acquisition Corporation - Effective Wednesday, November 25, 2008

      • To
      • Clearing Member Firms
      • From
      • CME Clearing
      • #
      • 08-370
      • Notice Date
      • 25 November 2008
      • Effective Date
      • 25 November 2008
    • ACTION:                                                           On November 20, 2008, Alaska Acquisition Corporation, a wholly-owned subsidiary of Eli Lilly and Company (LLY) completed its tender offer for ImClone Systems Incorporated (“IMCL”) Common Shares. The merger was subsequently consummated on November 24, 2008. As a result, each IMCL Common Share will be converted into the right to receive $70.00 net cash per share.
                                                                              This action will be coordinated with the Options Clearing Corporation.
      CATEGORY:                                                     Cash Settlement
      EQUITY SYMBOL:                                            ImClone Systems Incorporated (“IMCL”)
      ONE CHICAGO SYMBOL:                                 IMCL1C will be de-listed
      CME FUTURES SYMBOL:                                 IMC will be de-listed
      MULTIPLIER:                                                   100 (e.g., 1.00 equals $100.00)
      EFFECTIVE DATE:                                           Tuesday, November 25, 2008
      NEW DELIVERABLE PER CONTRACT:             $7,000 ($70.00 x 100)
      APPLICABLE CONTRACT MONTHS:                 December 2008 and January, March, June 2009
      SETTLEMENT PRICES AND POSITIONS:         The maturity date for all IMC1C Security Futures will be accelerated to November 25, 2008.
      NOTES:                                                            The forecasted effect of the upcoming corporate event on each clearing firms’ positions can be viewed in infopac in the Corporate Event Initial Forecast Report (ONE712), the Corporate Event Final Forecast Report (ONE713), and the Corporate Event Forecast Audit Report (CPDBU710).
                                                                              If you have any questions regarding the information provided in the document, please call CME Clearing risk management hotline at (312) 648-3888.